According to United Therapeutics's latest financial reports the company has ยฃ2.51 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | ยฃ2.60 B | 10.77% |
2023-12-31 | ยฃ2.35 B | 0.16% |
2022-12-31 | ยฃ2.34 B | 64.05% |
2021-12-31 | ยฃ1.43 B | 6.25% |
2020-12-31 | ยฃ1.34 B | 18.8% |
2019-12-31 | ยฃ1.13 B | 1.59% |
2018-12-31 | ยฃ1.11 B | 62.55% |
2017-12-31 | ยฃ0.68 B | -19.42% |
2016-12-31 | ยฃ0.85 B | 32.31% |
2015-12-31 | ยฃ0.64 B | 44.07% |
2014-12-31 | ยฃ0.44 B | 6.2% |
2013-12-31 | ยฃ0.42 B | 41.89% |
2012-12-31 | ยฃ0.29 B | 14.21% |
2011-12-31 | ยฃ0.25 B | -36.1% |
2010-12-31 | ยฃ0.40 B | 186.43% |
2009-12-31 | ยฃ0.14 B | -11.95% |
2008-12-31 | ยฃ0.16 B | 10.31% |
2007-12-31 | ยฃ0.14 B | 25.57% |
2006-12-31 | ยฃ0.11 B | 59.79% |
2005-12-31 | ยฃ72.76 M | 68.75% |
2004-12-31 | ยฃ43.12 M | 12.51% |
2003-12-31 | ยฃ38.32 M | -49.9% |
2002-12-31 | ยฃ76.49 M | 97.88% |
2001-12-31 | ยฃ38.65 M | -73.22% |
2000-12-31 | ยฃ0.14 B | 351.97% |
1999-12-31 | ยฃ31.93 M | 680.89% |
1998-12-31 | ยฃ4.08 M |